← Leaderboards
Naim Ur Rashid
Univ Of North Carolina Chapel Hill
$1,282,132
Attributed
$3,846,395
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,846,395 · 1
By mechanism
U01$3,846,395 · 1
Top collaborators
- Susan Tsai7 shared
- Jen Jen Yeh7 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles M Perou$46,508,459
- David N Hayes$17,915,459
- Jen Jen Yeh$14,819,320
- Lisa A Carey$11,034,788
- Andrew Olshan$26,924,096
Others in their field
Other Rising Stars on “Tumor”
- Kenneth Schultz · Trethera Corporation$7,146,643
- Jeff P Simko · Washington University$4,848,843
- Gary G Schwartz · University Of North Dakota$4,000,000
- Yicheng Wang · Immunova Therapeutics, Llc$4,000,000
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Daniel Francis · Claria Medical, Inc.$3,708,259
Research focus
TumorCellsTreatment ResponseTumor ProgressionNeoplastic CellAffectPatient-Focused OutcomesSignal TransductionTumor SubtypeHeterogeneityResponsePhosphotransferasesCoculture TechniquesClinical TrialsClinically RelevantCell CommunicationBiometryManuscriptsInnovationGenesClia CertifiedClinicClinical ApplicationCancer Biology
Grant awards (7)
Integrating tumor and stroma to understand and predict treatment response$914,890
U01 · FY2025 · CA
Integrating tumor and stroma to understand and predict treatment response$869,831
U01 · FY2024 · CA
Integrating tumor and stroma to understand and predict treatment response$85,780
U01 · FY2024 · CA
Integrating tumor and stroma to understand and predict treatment response$924,643
U01 · FY2023 · CA
Integrating tumor and stroma to understand and predict treatment response$90,295
U01 · FY2023 · CA
Effect of JAK and RIPK2 inhibition on CAF and cancer cell crosstalk$15,050
U01 · FY2023 · CA
Integrating tumor and stroma to understand and predict treatment response$945,906
U01 · FY2022 · CA